Danske Bank A/S (LON:0NVC)

Revance Therapeutics Cash Flow Statement

Financials in millions DKK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	23,372	23,629	21,262	-4,580	12,920	4,589
Depreciation & Amortization	1,026	1,026	4,244	4,706	4,876	6,304
Total Asset Writedown	-	-	-	1,627	-	-
Provision for Credit Losses	-544	-544	262	1,502	141	7,089
Change in Other Net Operating Assets	-177,970	-60,781	146,203	-96,357	-14,839	-21,531
Other Operating Activities	-1,094	-2,791	4,665	13,490	1,266	-3,193
Operating Cash Flow	-154,953	-39,204	176,746	-79,620	4,189	-6,549
Capital Expenditures	-847	-990	-841	-826	-686	-408
Sale of Property, Plant and Equipment	-	-	7	4	8	12
Cash Acquisitions	-21	-	-	-	-	-
Income (Loss) Equity Investments	257	257	110	-8	-175	193
Divestitures	-	26	45	2,032	-	5
Purchase / Sale of Intangibles	-1,669	-1,270	-540	-560	-885	-872
Investing Cash Flow	-2,537	-2,234	-1,329	650	-1,563	-1,263
Long-Term Debt Issued	-	40,446	22,425	20,052	14,454	27,331
Long-Term Debt Repaid	-	-47,670	-24,301	-31,201	-10,681	-2,833
Net Debt Issued (Repaid)	-8,359	-7,224	-1,876	-11,149	3,773	24,498
Repurchase of Common Stock	-5,153	-5,246	-	-5,419	-3,000	-5,600
Common Dividends Paid	-18,586	-12,777	-6,011	-1,705	-1,708	-
Net Increase (Decrease) in Deposit Accounts	60,543	-53,265	-35,246	-29,737	-41,751	193,055
Other Financing Activities	-	-	-	-164	-466	-625
Financing Cash Flow	23,015	-83,942	-43,133	-48,174	-43,152	211,328
Foreign Exchange Rate Adjustments	203	1,871	794	-3,322	2,634	-2,235
Net Cash Flow	-134,272	-123,509	133,078	-130,466	-37,892	201,281
Free Cash Flow	-155,800	-40,194	175,905	-80,446	3,503	-6,957
Free Cash Flow Margin	-275.81%	-70.58%	337.24%	-182.91%	7.39%	-17.77%
Free Cash Flow Per Share	-185.80	-47.30	204.53	-93.22	4.10	-8.15
Cash Income Tax Paid	7,682	10,335	4,565	3,025	2,459	4,315

Source: S&P Global Market Intelligence. Banks template. Financial Sources.